The Latin American Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.

Press releases published on October 27, 2026

Oct. 27, 2026

Bastion Trading Limited Reaches Agreement with SkyAI for Amendments to Tender Offer and Announces That It Will Tender All of Its SkyAI Securities

Indeterminate GlobeNewswire

Oct. 27, 2026

Oxbridge Re Announces 2026 Third Quarter Results on November 9, 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 3Q26

Indeterminate GlobeNewswire

Oct. 27, 2026

Revolution Medicines to Participate in November 2026 Investor Conferences

Indeterminate GlobeNewswire

Oct. 27, 2026

Arvinas Announces Return of Early Career Researcher Award to Recognize Innovation in Targeted Protein Degradation

Indeterminate GlobeNewswire

Oct. 27, 2026

Ligand to Participate in November Investor Conferences

Indeterminate GlobeNewswire

Oct. 27, 2026

Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation

Indeterminate GlobeNewswire

Oct. 27, 2026

Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference

Indeterminate GlobeNewswire

Oct. 27, 2026

Share-ify Unveils S.A.F.E. Score™, AI-Powered Supplier Risk Intelligence Across Its Food Safety and Compliance Portfolio

Indeterminate EIN Presswire

Oct. 27, 2026

Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers

Indeterminate GlobeNewswire

Oct. 27, 2026

Egetis Therapeutics Announces U.S. Launch of EMCITATE® for Patients with MCT8 Deficiency

Indeterminate GlobeNewswire

Oct. 27, 2026

Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Indeterminate GlobeNewswire

Oct. 27, 2026

Critical Metals Corp. Acquisition of European Lithium Becomes Effective

Indeterminate GlobeNewswire

Oct. 27, 2026

Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement

Indeterminate GlobeNewswire

Oct. 27, 2026

Clearmind Successfully Completes Patient Recruitment for the First Alcohol Use Disorder Cohort of its CMND-100 Phase I/IIa Clinical Trial

Indeterminate GlobeNewswire

Oct. 27, 2026

AssistRx Named a Central Florida Top Workplace for Sixth Consecutive Year

Indeterminate GlobeNewswire

Oct. 27, 2026

Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union

Indeterminate GlobeNewswire

Oct. 27, 2026

Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution

Indeterminate GlobeNewswire

Oct. 27, 2026

Humanitas Global Health Announces Launch and LSU DeepDrug License Agreement at AAPS PharmSci 360

Indeterminate GlobeNewswire